Read about upcoming changes to UnitedHealthcare coverage.
Weill Cornell Medicine is a nationally recognized leader in heart health, with a top-honored Mitral Valve Repair Reference Center, a comprehensive women’s heart health program and a Hypertrophic Cardiomyopathy (HCM) program that provides life-saving care to patients. Our physicians provide cardiac care with an individualized, multidisciplinary approach, while our world-class researchers are on the forefront of the latest breakthroughs. Here you'll find information on prevention, emerging technologies and clinical trials to help you live your best heart-healthy life.
Our doctors are sought-after experts in their field. Read their thoughts about heart health in the media.
December 04, 2025 Improving Detection of Aortic Aneurysms
November 21, 2025 Heart Health Breakfast Ideas
February 17, 2025 A heart attack scare turned out to be stress cardiomyopathy : NPR
February 12, 2025 How being in love impacts heart health: cardiologist
Learn about the latest heart health research at Weill Cornell Medicine.
Using Data and AI to Create Better Health Care Systems | Newsroom | Weill Cornell Medicine | Weill Department of Medicine June 26, 2025
Loneliness Linked to Higher Risk of 30-Day Hospital Return After Heart Attack | Weill Cornell Medicine December 17, 2025
A Crucial Step to Improve Care in Heart Failure: Integrating Home Health Care into Learning Health System | Weill Department of Medicine August 14, 2025
Dr. Madeline R. Sterling Releases Scientific Statement on American Heart Association’s Life’s Essential 8 | Weill Department of Medicine December 17, 2024
Weill Cornell Medicine is a leader in innovation, providing cutting-edge treatments to improve outcomes and deliver on our promise of personalized care.
Leveraging Digital Technology to Empower Prevention:
“We’re [piloting] electronic medical support to identify patients who have very high cholesterol and flagging them to their PCP [for follow up].”
-Dr. Samuel Kim
Targeting Better Diagnoses and Treatments:
“We are focusing now on microvascular dysfunction, which affects predominantly females, and unfortunately, has historically been difficult to diagnose. We’re currently building a program to decide if certain interventional tests make sense and can help tailor therapy.”
-Dr. Jaya Kanduri
Studying Patients’ Long-Term Health Effects:
"We're participating in an international, multicenter registry looking at patients who receive immune checkpoint inhibitors, which can help us better understand immune checkpoint inhibitor myocarditis.”
-Dr. Stephanie Feldman
